NeuroPanels: June 2024 Sleep CaseS
Course Description
Our host, José Posas, MD, FAAN, is joined by Logan Schneider, MD and Margaret Kay-Stacey, MD. First, we will discuss a case of persistent hypersomnia, despite being on supposedly appropriate therapy. Next we’ll review a case looking looking for the reason for the patient’s “spells”. We will have expert discussion for the last half of the webinar with audience participation and Q&A.
DATE OF Live Webinar
Tuesday, May 21st - 06:00 PM - 07:00 PM CTAMA Credit Designation Statement
The American Academy of Neurology Institute (AANI) designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Learning Objectives
As a result of this self-assessment activity, the learner will be able to:
- Identify the key diagnostic features of narcolepsy and how they can overlap with other sleep conditions, which can often delay the diagnosis of narcolepsy or distort the clinical picture.
- Understand the work up for a patient with suspected narcolepsy and the limitations of the clinical testing (actigraphy/sleep diary, overnight polysomnogram and multiple sleep latency test). Identify when to consider testing the patient’s CSF for hypocretin/orexin levels.
- Identify characteristics of cataplexy as differentiated from other types of spells (eg, duration, maintenance of awareness, progressive loss and rapid resumption of muscle tone, preserved eye movements, etc.).
- Enumerate the pentad of symptoms associated with narcolepsy: cataplexy, excessive daytime sleepiness (EDS), hypnagogic/hypnopompic hallucinations, sleep paralysis, disrupted nocturnal sleep.
Confidentiality of Data
All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved. See complete
Terms of Use.
Accreditation
The American Academy of Neurology Institute (AANI), a subsidiary of the American Academy of Neurology (AAN), is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.UNLABELED USE DISCLOSURE
The AANI requires all NeuroPanels presenters to disclose if a therapy/product is not labeled for the use being discussed or if the therapy/product is still investigational.HOST
Jose Posas, III, MDAttending Physician in Neurology
Neurology Residency Program Director, Ochsner Clinic Foundation
New Orleans, LA
* Dr. Posas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Peerlink Medical. Dr. Posas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Elite Medical Experts.
PANELISTS & DISCLOSURES
Logan Schneider, MDStaff Neurologist
Stanford/VA Alzheimer's Research Center
Palo Alto, CA Clinical Assistant Professor (affiliated) of Sleep Medicine
Stanford Sleep Center
Palo Alto, CA
* Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care. .
Margaret Kay-Stacey
Assistant Professor of Neurology
Ambulatory Medical Director, Neurology
University of Chicago Medicine
Chicago, IL
* Dr. Kay-Stacey has nothing to disclose.
MODERATORS
Nathan Nowalk, MDPulmonary and Critical Care Fellow
University of Chicago Medicine
Chicago, IL
*Dr. Nowalk has nothing to disclose.
Pahnwat Tonya Taweesedt, MD
Postdoctral Fellow
Stanford University School of Medicine
Palo Alto, CA
*Dr. Taweesedt has nothing to disclose.
NeuroPanels Staff
Xiaoyu SunAssociate Director, eLearning
Minneapolis, MN
*Ms. Sun has nothing to disclose.
Bobby Rook
Manager, eLearning
Minneapolis, MN
*Mr. Rook has nothing to disclose.
*Relationship Disclosure